Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 4/20 | 1.00 |
| ▸ | GRIA3 | P42263 | 4/20 | 1.00 |
| ▸ | GRIA2 | P42262 | 3/20 | 1.00 |
| ▸ | GRIA4 | P48058 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.47 |
| ▸ | GRIK4 | Q16099 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2036595 | 1.00 | GRIA1 (1.00) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| SCHEMBL13957545 | 0.87 | GRIA1 (0.78) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| SCHEMBL14945013 | 0.87 | GRIA1 (0.78) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| SCHEMBL7167719 | 0.83 | GRIA1 (0.71) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| SCHEMBL7167715 | 0.83 | GRIA1 (0.71) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| SCHEMBL8812978 | 0.77 | GRIA1 (0.71) | GRIA1GRIA3GRIA2GRIA4BLM | |
| SCHEMBL8812980 | 0.77 | GRIA1 (0.71) | GRIA1GRIA3GRIA2GRIA4BLM | |
| (R,S)-Ampa SCHEMBL2458874 | 0.76 | GRIA1 (0.69) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| (R,S)-Ampa SCHEMBL68799 | 0.76 | GRIA1 (0.69) | GRIA1GRIA3GRIA2GRIA4HIF1A | |
| (S)-Ampa SCHEMBL667915 | 0.76 | GRIA1 (0.69) | GRIA1GRIA3GRIA2GRIA4HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120875604-B | Intelligent evaluation system and method for soil ecological function | 广西壮族自治区国有七坡林场 | 2026-05-12 | — | — | CN | claimed |
| CN-118599738-B | Preparation method of organic contaminated soil carbon fixation and decontamination functional flora | 南京农业大学 | 2025-01-03 | — | — | CN | claimed |
| CN-118599738-A | Preparation method of organic contaminated soil carbon fixation and decontamination functional flora | 南京农业大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118388028-A | Method for realizing shortcut nitrification starting and maintaining by combining hydroxylamine with high-dissolved oxygen to inhibit nitrite oxidizing bacteria and whole-process ammonia oxidizing bacteria | 生态环境部土壤与农业农村生态环境监管技术中心 | 2024-07-26 | — | — | CN | claimed |
| CN-114350763-B | Method for identifying nitrifying microorganism | 中国科学院城市环境研究所 | 2024-04-30 | — | — | CN | claimed |
| CN-117343914-B | Modified ammonia monooxygenase, carrier, microorganism and method for ammonia nitrogen degradation | 四川水王子环境科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117467780-A | Determination method of heterotrophic nitrification-aerobic denitrification bacterial nitrogen metabolic pathway | 浙江大学 | 2024-01-30 | — | — | CN | claimed |
| CN-117343914-A | Modified ammonia monooxygenase, carrier, microorganism and method for ammonia nitrogen degradation | 四川水王子环境科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| US-11834737-B2 | Titanium alloy coating film and titanium alloy target material | DAIDO STEEL CO., LTD. (JP) | 2023-12-05 | — | — | US | claimed |
| CN-113189291-B | Natural water system water quality condition assessment method and application thereof | 广州绿曦生物科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-112951330-B | Method for obtaining relative abundance and activity of whole-course ammonia oxidizing microorganisms from complex environment system based on macro-composition technology | 北京大学 | 2022-09-27 | — | — | CN | claimed |
| WO-2011076946-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER | Universidad Del País Vasco (ES) | 2011-06-30 | — | — | WO | claimed |
| US-7101879-B2 | Treatments for neurotoxicity in Alzheimer's Disease | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-09-05 | — | — | US | claimed |
| US-20040152694-A1 | Methods and compositions for treating inflammatory disorders of the airways | IVAX DRUG RESEARCH INSTITUTE, LTD. | 2004-08-05 | — | — | US | claimed |
| EP-1015013-A4 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES | MASSACHUSETTS INST TECHNOLOGY (US) | 2002-07-24 | — | — | EP | claimed |
| US-6172043-B1 | GENETIC ENGINEERED POLYPEPTIDE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-01-09 | — | — | US | claimed |
| EP-1015013-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-07-05 | — | — | EP | claimed |
| WO-1998030229-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY β-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-07-16 | — | — | WO | claimed |
| CN-118084188-B | Method for accelerating short-cut nitrification starting during sludge pretreatment | SHANGHAI UNIVERSITY OF ELECTRIC POWER (CN) | 2026-05-26 | — | — | CN | disclosed |
| WO-1998030229-A1 | TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY β-AMYLOID PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152694-A1 | Methods and compositions for treating inflammatory disorders of the airways | LTB4R2, LTB4R, LTC4S | GRIA1 2085/4885GRIA3 2201/4885GRIA2 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.